InsidersTradesSigma
Follow the 팜젠사이언스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 팜젠사이언스 has recorded 91 reports. Market capitalisation: €75.4bn. The latest transaction was disclosed on 12 May 2026 (Purchase). Among the most active insiders: 한의상. The full history is free.
91
Insider Decl.
n/a
Thresholds
€2m
72 ops.
Buy Volume
n/a
3 ops.
Sell Volume
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,057 of 29,056 companies
33.9
score / 100
Value31
Quality37
FCF yld3.8%
Earn yld-166%
EV/EBITDA·
ROE0.1%
Gross mgn65%
Net mgn-67%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 May 2026
Declarations91 total
25 of 91 declarations
关于 팜젠사이언스
Farmgen Science 是一家在XKRX市场上市的健康和制药领域的公司。它专注于创新药物解决方案的开发。